Neurotune AG
Records under this name other than the patents Neurotune AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 7 of 7 · Back to Neurotune AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,685,915 | Modified agrin-fragment capable of restoring muscle strength for use as a medicament Lapsed on the fee record Ended Apr 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2026 | From the USPTO record |
| US 8,476,453 | Process for the preparation of dimiracetam Lapsed on the fee record Ended Jul 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 2, 2025 | From the USPTO record |
| US 8,334,286 | Substituted pyrrolo[1,2-A] pyrazines, compositions containing these, processes of making these, and uses thereof Lapsed on the fee record Ended Dec 18, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 18, 2024 | From the USPTO record |
| US 9,125,898 | Acetam derivatives for pain relief Lapsed on the fee record Ended Sep 8, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2023 | From the USPTO record |
| US 7,973,066 | Pyrrolo[1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents Lapsed on the fee record Ended Jul 5, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 5, 2015 | From the USPTO record |
| US 7,732,473 | Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof Lapsed on the fee record Ended Jun 8, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 8, 2014 | From the USPTO record |
| US 7,544,705 | Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents Lapsed on the fee record Ended Jun 9, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jun 9, 2013 | From the USPTO record |